Baculovirus gene delivery: A flexible assay development tool

Current Gene Therapy

Volumn 10, Issue 3, 2010, Pages 168-173

  Kost, Thomas A ^a   Condreay, J Patrick ^a   Ames, Robert S ^b  

^a GLAXOSMITHKLINE   (United States)

^b Molecular Discovery Research   (United States)

Author keywords

BacMam; Cell based assays; HTS; SAR

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BACULOVIRUS VECTOR; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; CELL NUCLEUS RECEPTOR; CONSTITUTIVELY ACTIVE POTASSIUM CHANNEL; ENHANCED GREEN FLUORESCENT PROTEIN; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; PURINERGIC P2X7 RECEPTOR; RNA POLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL LINE; GENE EXPRESSION; HUMAN; MAMMAL CELL; NONHUMAN; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; BACULOVIRIDAE; CELL LINE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES; MAMMALS;

MAMMALIA;

EID: 77953661678     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310791321224     Document Type: Article

References (83)

1. Cawkill D, Eaglestone SS. Evolution of cell-based reagent provision. Drug Discov Today 2007; 12: 820-25.
2. Rees S, Wise A. The industrialization of cellular screening. Expert Opin Drug Discov 2008; 3: 715-23.
3. Mayr LM, Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009; 9: 580-8.
4. An WF, Tolliday N. Cell-based assays for high-throughput screening. Mol Biotechnol 2010; [Epub ahead of print].
5. Kramer BP, Fussenegger M. Transgene control engineering in mammalian cells. Methods Mol Biol 2005; 308: 123-43.
6. Bianchi BR, Moreland RB, Faltynek CR et al. Application of large-scale transiently transfected cells to functional assays of ion channels: different targets and assay formats. Assay Drug Dev Technol 2007; 5: 417-24.
7. Chen J, Lake MR, Sabet RS et al. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists. J Biomol Screen 2007; 12: 61-9.
8. Odani N, Ito K, Nakamura H. Electroporation as an efficient method of gene transfer. Dev Growth Differ 2008; 50: 443-8.
9. Geisse S. Reflections on more than 10 years of TGE approaches. Protein Expr Purif 2009; 64: 99-107.
10. Pathak A, Patnaik S, Gupta KC. Recent trends in non-viral vector-mediated gene delivery. Biotechnol J 2009; 4: 1559-72.
11. Ames RS, Lu Q. Viral-mediated gene delivery for cell based-assays in drug discovery. Expert Opin Drug Discov 2009; 4: 243-56.
12. Howarth JL, Lee YB, Uney JB. Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). Cell Biol Toxicol 2010; 26: 1-20.
13. Kost TA, Condreay JP. Baculovirus vectors as gene transfer vectors for mammalian cells: biosafety considerations. Appl Biosafe 2002; 7: 167-9.
14. Kost TA, Condreay JP, Mickelson CA. Biosafety and viral gene transfer vectors. In: Fleming DO, Hunt DL Eds, Biological safety: principles and practices. Washington, D. C., ASM press. 2006; pp 509-30.
15. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotech-nol 2005; 23: 567-75.
16. Hitchman RB, Possee RD, King LA. Baculovirus expression systems for recombinant protein production in insect cells. Recent Pat Biotechnol 2009; 3: 46-54.
17. Jarvis DL. Baculovirus-insect cell expression systems. Methods Enzymol 2009; 463: 191-222.
18. Hassan NJ, Gul S, Flett F et al. Development of an insect-cell-based assay for detection of kinase inhibition using NF-kappaB-inducing kinase as a paradigm. Biochem J 2009; 419: 65-73.
19. Xu Y, Wang J, Bao Y et al. Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model. Anal Biochem 2010; 400(2): 207-12.
20. Loisel TP, Ansanay H, St-Onge S, et al. Recovery of homogeneous and functional beta 2-adrenergic receptors from extracellular baculovirus particles 9. Nat Biotechnol 1997; 15: 1300-04.
21. Saitoh R, Ohtomo T, Ito Y et al. Recovery of functional peptide transporter PepT1 in budded baculovirus fraction. Protein Expr Purif 2006; 46: 130-5.
22. Rohrmann GF. Baculovirus molecular biology. Bethesda, MD, National Library of Science (US) NCBI; 2008.
23. Smith GE, Summers MD, Fraser MJ. Production of human beta interferon in insect cells infected with a baculovirus expression vector. 1983. Biotechnology 1992; 24: 434-43.
24. Pennock GD, Shoemaker C, Miller LK. Strong and regulated expression of Escherichia coli beta-galactosidase in insect cells with a baculovirus vector. Mol Cell Biol 1984; 4: 399-406.
25. Hofmann C, Sandig V, Jennings G et al. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10099-103.
26. Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348-52.
27. Shoji I, Aizaki H, Tani H et al. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 1997; 78 (Pt 10): 2657-64.
28. Yap CC, Ishii K, Aoki Y et al. A hybrid baculovirus-T7 RNA polymerase system for recovery of an infectious virus from cDNA. Virology 1997; 231: 192-200.
29. Condreay JP, Witherspoon SM, Clay WC et al. Transient and stable gene expression in mammalian cells transduced with a recom-binant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127-32.
30. Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 2002; 20: 173-80.
31. Barsoum J. Concentration of recombinant baculovirus by cation-exchange chromatography. Biotechniques 1999; 26: 834-6, 838,40.
32. Transfiguracion J, Jorio H, Meghrous J et al. High yield purification of functional baculovirus vectors by size exclusion chromatog-raphy. J Virol Methods 2007; 142: 21-8.
33. Wu C, Soh KY, Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant bacu-lovirus and baculovirus gp64 protein. Hum Gene Ther 2007; 18:665-72.
34. Vicente T, Peixoto C, Carrondo MJ et al. Purification of recombi-nant baculoviruses for gene therapy using membrane processes. Gene Ther 2009; 16: 766-75.
35. Jarvis DL, Garcia A, Jr. Long-term stability of baculoviruses stored under various conditions. Biotechniques 1994; 16: 508-13.
36. Spenger A, Ernst W, Condreay JP, et al. Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Protein Expr Purif 2004; 38: 17-23.
37. Condreay JP, Ames RS, Hassan NJ, et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res 2006;68: 255-86.
38. Ames RS, Kost TA, Condreay JP. BacMam technology and its application to drug discovery. Expert Opin Drug Discov 2007; 2: 1669-81.
39. Kost TA, Condreay JP, Ames RS, et al. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 2007; 12: 396-403.
40. Song SU, Shin SH, Kim SK et al. Effective transduction of os-teogenic sarcoma cells by a baculovirus vector. J Gen Virol 2003;84: 697-703.
41. McLoughlin DJ, Bertelli F, Williams C. The A, B, Cs of G-protein coupled receptor pharmacology in assay development for HTS. Expert Opin Drug Discov 2010; 2: 603-19.
42. Heilker R, Wolff M, Tautermann CS et al. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today 2009; 14: 231-40.
43. Ames R, Fornwald J, Nuthulaganti P et al. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Recept Channels 2004; 10: 99-107.
44. Ames RS, Nuthulaganti P, Fornwald JA, et al. Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells. Recept Channels 2004; 10: 117-24.
45. Behm DJ, Stankus G, Doe CP, et al. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems. Br J Pharmacol 2006; 148: 173-90.
46. Watson C, Jenkinson S, Kazmierski W, et al. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncom-petitive HIV entry inhibitor. Mol Pharmacol 2005; 67: 1268-82.
47. Kenakin T, Jenkinson S, Watson C. Determining the potency and molecular mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 2006; 319: 710-23.
48. Sanger GJ, Tuladhar BR, Brown J, et al. Modulation of peristalsis by NK3 receptor antagonism in guinea-pig isolated ileum is revealed as intraluminal pressure is raised. Auton Autacoid Pharmacol 2007; 27: 105-11.
49. Briscoe CP, Peat AJ, McKeown SC, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules 2. Br J Pharmacol 2006; 148: 619-28.
50. Medhurst AD, Atkins AR, Beresford IJ, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in pre-clinical models. J Pharmacol Exp Ther 2007; 321: 1032-45.
51. Garippa RJ, Hoffman AF, Gradl G, et al. High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec Opera. Methods Enzymol 2006; 414: 99-120.
52. Oakley RH, Hudson CC, Sjaastad MD, et al. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment. Methods Enzymol 2006; 414: 50-63.
53. Hoffman AF, Garippa RJ. A pharmaceutical company user's perspective on the potential of high content screening in drug discovery. Methods Mol Biol 2007; 356: 19-31.
54. Rominger CM, Bee WL, Copeland RA, et al. Evidence for allos-teric interactions of antagonist binding to the smoothened receptor. J Pharmacol Exp Ther 2009; 329: 995-1005.
55. Huwiler KG, Machleidt T, Chase L, et al. Characterization of serotonin 5-hydroxytryptamine-1A receptor activation using a phospho-extracellular-signal regulated kinase 2 sensor. Anal Biochem 2009; 393: 95-104.
56. Camerino DC, Desaphy JF, Tricarico D, et al. Therapeutic approaches to ion channel diseases. Adv Genet 2008; 64: 81-145.
57. Pfohl JL, Worley JF, III, Condreay JP, et al. Titration of KATP channel expression in mammalian cells utilizing recombinant bacu-lovirus transduction. Recept Channels 2002; 8: 99-111.
58. Clare JJ. Functional expression of ion channels in mammalian systems. In: Clare JJ, Trezise DJ, Eds, Expression and analysis of recombinant ion channels. Weinheim, Wiley-VCH. 2006; pp. 79-109.
59. Fonfria E, Clay WC, Levy DS, et al. Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue. Br J Pharmacol 2008; 153: 544-56.
60. Roman S, Cusdin FS, Fonfria E, et al. Cloning and pharmacological characterization of the dog P2X7 receptor. Br J Pharmacol 2009; 158: 1513-26.
61. Michel AD, Clay WC, Ng SW, et al. Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects. Br J Pharmacol 2008; 155: 738-51.
62. Raschi E, Ceccarini L, De PF, et al. hERG-related drug toxicity and models for predicting hERG liability and QT prolongation. Expert Opin Drug Metab Toxicol 2009; 5: 1005-21.
63. Titus SA, Beacham D, Shahane SA, et al. A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel. Anal Biochem 2009; 394: 30-8.
64. Hassan NJ, Pountney DJ, Ellis C, et al. BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1. Protein Expr Purif 2006; 47: 591-8.
65. Chen T. Nuclear receptor drug discovery. Curr Opin Chem Biol 2008; 12: 418-26.
66. Clay WC, Condreay JP, Moore LB, et al. Recombinant baculovi-ruses used to study estrogen receptor function in human osteosar-coma cells. Assay Drug Dev Technol 2003; 1: 801-10.
67. Boudjelal M, Mason SJ, Katso RM, et al. The application of BacMam technology in nuclear receptor drug discovery. Biotech-nol Annu Rev 2005; 11: 101-25.
68. Katso RM, Parham JH, Caivano M, et al. Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant bacu-loviruses. J Biomol Screen 2005; 10: 715-24.
69. Wang DY, Lu Q, Walsh SL, et al. Development of a high-throughput cell-based assay for 11beta-hydroxysteroid dehydro-genase type 1 using BacMam technology. Mol Biotechnol 2008; 39: 127-34.
70. Carlson CB, Mashock MJ, Bi K. BacMam-enabled lanthaScreen(R) cellular assays for PI3K/Akt pathway compound profiling in disease-relevant cell backgrounds. J Biomol Screen 2010, [Epub ahead of Print].
71. Delaney WE, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovi-rus. Hepatology 1998; 28: 1134-46.
72. Isom HC, Abdelhamed AM, Bilello JP, et al. Baculovirus-mediated gene transfer for the study of hepatitis B virus. Methods Mol Med 2004; 96: 219-37.
73. Fipaldini C, Bellei B, La MN. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovi-rus-HCV vector. Virology 1999; 255: 302-11.
74. McCormick CJ, Rowlands DJ, Harris M. Efficient delivery and regulable expression of hepatitis C virus full-length and minige-nome constructs in hepatocyte-derived cell lines using baculovirus vectors. J Gen Virol 2002; 83: 383-94.
75. McCormick CJ, Challinor L, Macdonald A, et al. Introduction of replication-competent hepatitis C virus transcripts using a tetracy-cline-regulable baculovirus delivery system. J Gen Virol 2004; 85:429-39.
76. Matsuo E, Tani H, Lim C, et al. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. Biochem Biophys Res Commun 2006; 340: 200-8.
77. Adair R, Patel AH, Corless L, et al. Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA. J Gen Virol 2009; 90: 833-42.
78. Yao X, Han Q, Song J, et al. Baculovirus mediated production of infectious hepatitis C virus in human hepatoma cells stably expressing T7 RNA polymerase. Mol Biotechnol 2008; 40: 186-94.
79. Pan Y, Zhao Q, Fang L, et al. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cy-tomegalovirus promoter/Semliki Forest virus replicon. J Gene Med 2009; 11: 1030-8.
80. Cheshenko N, Krougliak N, Eisensmith RC, et al. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 2001; 8: 846-54.
81. Keil GM, Klopfleisch C, Giesow K, et al. Novel vectors for simultaneous high-level dual protein expression in vertebrate and insect cells by recombinant baculoviruses. J Virol Methods 2009; 160: 132-7.
82. Hsu CS, Ho YC, Wang KC et al. Investigation of optimal transduc-tion conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 2004; 88: 42-51.
83. Airenne KJ. Optimization of baculovirus-mediated gene delivery into vertebrate cells. Bioprocess J 2009; 8: 54-9.